跳至主要内容
临床试验/CTRI/2025/02/080690
CTRI/2025/02/080690已完成不适用

TO ELICIT THE EFFICACY OF FERRUM PHOSPHORICUM 6X IN MANAGEMENT OF IRON DEFICIENCY ANAEMIA IN YOUNG FEMALES - A RANDOMISED CONTROLLED CLINICAL TRIAL

KLE Academy of Higher Education (KAHER)1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Homoeopathic medicine Ferrum Phosphoricum 6X is able to improve the Haemoglobin in females included in study.

研究概览

简要总结

Step 01: Subjects with signs and symptoms of Anaemia are screened.

Step 02: Subjects with signs and symptoms of anaemia are investigated for Iron Profile [Complete Blood Count, Serum Iron, Serum Ferritin, Total Iron Binding Capacity (TIBC)]. Subjects with Hb below 11gm% are included.

Step 03: Subjects selected are given Ferrum Phosphoricum 6X (2-0-2) is given for 03 months.

Step 04: Post treatment, subjects are investigated for Iron Profile [Complete Blood Count, Serum Iron, Serum Ferritin, Total Iron Binding Capacity (TIBC)].

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant Blinded

入排标准

年龄范围
16.00 Year(s) 至 22.00 Year(s)(—)
性别
Female

入选标准

  • Haemoglobin percentage 08-11 gm%.

排除标准

  • Male subjects
  • Female subjects below 14 years of age and above 22 years of age.
  • Subjects with congenital hemolytic disease.
  • Bone marrow depressive cases due to any drugs.
  • Anaemia due to traumatic injury, accidents, poisoning cases or any other terminal illness.

结局指标

主要结局

Homoeopathic medicine Ferrum Phosphoricum 6X is able to improve the Haemoglobin in females included in study.

时间窗: 03 months of ferrum phosphoricum 6X tablet (2-0-2)

次要结局

  • Homoeopathy as a potential alternative treatment option for Iron deficiency Anaemia(At the end of study)

研究者

发起方
KLE Academy of Higher Education (KAHER)
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Channagouda S Ramagondi

KLE Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验